Log In
BCIQ
Print this Print this
 

Toll-like receptor 9 (TLR9)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Toll-like receptor 9 (TLR9)

BCIQ
Print ChartPrint this
1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 3 0 1 0 0 1 1 0 1 2 0 0 0 0 1 0 0 0 0 3 4 2 2 1 1 2 0 2 1
Phases of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase III
Autoimmune

1

2

0

2

1

Cancer

3

4

2

2

1

Cardiovascular

1

0

0

0

0

Endocrine / Metabolic

2

0

0

0

0

Infectious

0

1

1

0

1

Inflammation

1

3

0

1

0

Neurology

0

0

0

1

0

Other

0

0

0

0

1

Pulmonary

1

0

0

0

0




 Products Targeting Toll-like receptor 9 (TLR9)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

6

$849.6M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today